Novartis cancer drug may also work for Parkinson's
Berlin
A NOVARTIS AG drug used for treating leukemia may also work for patients with Parkinson's disease, judging from one small and early clinical test.
An early stage trial conducted by the Georgetown University Medical Center found a small dose of the medicine, Tasigna, produced "meaningful clinical improvements" in 10 out of 11 patients, the university said in a statement on Saturday. Unlike standard clinical tests, this one did not include a control group for comparison.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Possible class action lawsuit against Cordlife by customers could take at least 2 years
Chinese tariffs could leave cognac makers with too much brandy
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share